We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.2B
AUM Growth
+$6.6B
Cap. Flow
+$3.75B
Cap. Flow %
16.89%
Top 10 Hldgs %
18.16%
Holding
1,735
New
565
Increased
342
Reduced
340
Closed
467

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$239M
2
AAPL icon
Apple
AAPL
+$213M
3
ELV icon
Elevance Health
ELV
+$188M
4
BMY icon
Bristol-Myers Squibb
BMY
+$184M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$166M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$183M
2
ABBV icon
AbbVie
ABBV
+$149M
3
HUM icon
Humana
HUM
+$120M
4
FIS icon
Fidelity National Information Services
FIS
+$119M
5
MELI icon
Mercado Libre
MELI
+$103M

Sector Composition

Rank Sector Weight
1 Healthcare 27.33%
2 Technology 17.93%
3 Consumer Discretionary 11.98%
4 Financials 8.85%
5 Communication Services 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
151
Moderna
MRNA
$23.6B
$37.5M 0.17%
+358,694
New +$36.3M
VEEV icon
152
Veeva Systems
VEEV
$37.4B
$37.3M 0.17%
137,033
-30,622
-18% -$8.58M
LAD icon
153
Lithia Motors
LAD
$8.26B
$37.3M 0.17%
127,422
+91,418
+254% +$25M
AEP icon
154
American Electric Power
AEP
$68.4B
$36.3M 0.16%
+435,993
New +$37.8M
AMAT icon
155
Applied Materials
AMAT
$428B
$35.8M 0.16%
414,789
+384,827
+1,284% +$28.4M
BHP icon
156
BHP
BHP
$230B
$35.5M 0.16%
609,759
+578,141
+1,829% +$29M
BMRN icon
157
BioMarin Pharmaceuticals
BMRN
$12.4B
$35.5M 0.16%
404,687
-588,168
-59% -$46.6M
GDDY icon
158
GoDaddy
GDDY
$11.5B
$35.3M 0.16%
425,995
-111,649
-21% -$8.77M
NARI
159
DELISTED
Inari Medical, Inc. Common Stock
NARI
$35.3M 0.16%
404,382
+395,127
+4,269% +$27.9M
CHE icon
160
Chemed
CHE
$7.22B
$34.9M 0.16%
65,604
-8,881
-12% -$4.36M
TRU icon
161
TransUnion
TRU
$15.3B
$34.9M 0.16%
351,554
-55,224
-14% -$5.06M
NFLX icon
162
Netflix
NFLX
$309B
$34.9M 0.16%
644,860
+624,760
+3,108% +$31.7M
KEYS icon
163
Keysight
KEYS
$58.3B
$34.5M 0.16%
261,283
-183,346
-41% -$21.1M
SEE
164
CALL
DELISTED
Sealed Air
SEE
$34.1M 0.15%
+745,000
New +$32.3M
BBY icon
165
Best Buy
BBY
$17.3B
$33.9M 0.15%
339,461
-60,630
-15% -$6.78M
ARNA
166
DELISTED
Arena Pharmaceuticals Inc
ARNA
$33.6M 0.15%
437,876
-559,520
-56% -$41.9M
SO icon
167
Southern Company
SO
$107B
$33.6M 0.15%
+546,622
New +$32.9M
CCXI
168
DELISTED
ChemoCentryx, Inc.
CCXI
$33.5M 0.15%
541,390
-385,292
-42% -$22.1M
DUK icon
169
Duke Energy
DUK
$97.3B
$33.5M 0.15%
365,363
+347,670
+1,965% +$32.2M
OXY.WS icon
170
CALL
Occidental Petroleum Corp Warrants
OXY.WS
$32B
$33.1M 0.15%
+1,914,433
New +$8.68M
MTDR icon
171
Matador Resources
MTDR
$6.09B
$32.8M 0.15%
2,716,317
+2,210,406
+437% +$21.6M
TDG icon
172
TransDigm Group
TDG
$67.7B
$32.5M 0.15%
52,536
-7,304
-12% -$4.02M
FRC
173
DELISTED
First Republic Bank
FRC
$32.5M 0.15%
220,970
+81,713
+59% +$10.6M
AMT icon
174
American Tower
AMT
$80.4B
$32.4M 0.15%
144,136
+105,942
+277% +$24.6M
SPGI icon
175
S&P Global
SPGI
$120B
$32.1M 0.14%
97,776
+39,942
+69% +$13.5M
5 6
7
8 9

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace North America held 1,735 positions worth $22.2B, up 42% from $15.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $3.75B of net new capital in Q4 2020, opening 565 new positions and adding to 342 existing holdings. Its largest new stake was ExxonMobil: 2,686,885 shares worth $111M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Adobe, an estimated $183M trimmed.

  • Marshall Wace North America's largest Q4 2020 buy was ExxonMobil: 2,686,885 shares worth $111M.
  • Marshall Wace North America added most to Thermo Fisher Scientific in Q4 2020, an estimated $239M increase.
  • Marshall Wace North America's biggest Q4 2020 reduction was Adobe, cutting an estimated $183M.
  • Marshall Wace North America fully exited Baxter International in Q4 2020, selling an estimated $92.8M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $22.2B portfolio in Q4 2020.
  • Marshall Wace North America opened 565 new positions and closed 467 in Q4 2020.
  • Marshall Wace North America's portfolio value rose 42% quarter-over-quarter to $22.2B.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.